Janssen Pharmaceuticals is seeking to move the growing litigation over its diabetes medication Invokana from state to federal court.
Drugmaker Janssen Pharmaceuticals recently filed notices in more than 100 cases pending in the Philadelphia Court of Common Pleas indicating it removed the cases to federal court. Although the copies of the notices of removal were filed in state court on Nov. 17, the notices were initially filed in the U.S. District Court for the Eastern District of Pennsylvania in early November.
